title: [Current treatment strategies with novel agents for multiple myeloma].
authors: Michihide
authors: M
authors: Tokuhira
mesh_terms: D001897:Boronic Acids / Q000009:adverse effects / Q000627:therapeutic use; D000069286:Bortezomib; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D015195:Drug Design; D004359:Drug Therapy, Combination; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D000077269:Lenalidomide; D058990:Molecular Targeted Therapy / Q000639:trends*; D009101:Multiple Myeloma / Q000628:therapy*; D011719:Pyrazines / Q000009:adverse effects / Q000627:therapeutic use; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D014182:Transplantation, Autologous
chemical_list: D001897:Boronic Acids; D011719:Pyrazines; D013792:Thalidomide; D000069286:Bortezomib; D000077269:Lenalidomide